¼¼°èÀÇ ½ÅÁ¾ Äڷγª¹ÙÀÌ·¯½º °¨¿°Áõ(COVID-19) °ü·Ã Á¦Ç° ¹× ¼­ºñ½º ½ÃÀå ¿¹Ãø(-2024³â)
COVID-19 Mitigation Products (PPE, Serologic Test, Contact Tracing, COVID-19 Drugs, COVID-19 Vaccine, Polymerase Chain Reaction, PCR Test Kits, Blockchain Technologies, Surge Hospitals, Self-collection Swabs, and More) Market Research to 2024
»óǰÄÚµå : 955004
¸®¼­Ä¡»ç : Homeland Security Research Corporation (HSRC)
¹ßÇàÀÏ : 2020³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 1020 Pages; 738 Tables & Figures
US $ 5,950 £Ü 7,599,000
PDF (Single User License)
US $ 6,950 £Ü 8,876,000
PDF (Departmental License)
US $ 8,950 £Ü 11,430,000
PDF (Site License)
US $ 12,000 £Ü 15,326,000
PDF (Corporate License)


Çѱ۸ñÂ÷

¼¼°èÀûÀÎ ÆÒµ¥¹ÍÀ» ¹è°æÀ¸·Î »õ·Î¿î ½ÃÀåÀÎ ½ÅÁ¾ Äڷγª¹ÙÀÌ·¯½º °¨¿°Áõ(COVID-19) ÆÒµ¥¹Í °ü·Ã Á¦Ç° ¹× ¼­ºñ½º ½ÃÀåÀÌ µîÀåÇϰí ÀÖ½À´Ï´Ù. ½Ã³ª¸®¿À¿¡ ÀÇÇϸé 2020-2024³â ´©Àû ½ÃÀå ±Ô¸ð´Â 1Á¶ 6,000¾ï ´Þ·¯(³«°üÀû ½Ã³ª¸®¿À)¿Í 2Á¶ 2,000¾ï ´Þ·¯(º¸¼öÀû ½Ã³ª¸®¿À)°¡ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÆÒµ¥¹ÍÀÇ ÇâÈÄ´Â ¿¹ÃøÇÒ ¼ö ¾ø±â ¶§¹®¿¡ º» º¸°í¼­¿¡´Â 2°³ÀÇ ½Ã³ª¸®¿À°¡ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù.

¼¼°èÀÇ ½ÅÁ¾ Äڷγª¹ÙÀÌ·¯½º °¨¿°Áõ(COVID-19) °ü·Ã Á¦Ç° ¹× ¼­ºñ½º ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇßÀ¸¸ç, COVID-19ÀÇ °³¿ä, °ü·Ã Á¦Ç°/¼­ºñ½º ½ÃÀå, ¾÷Á¾º° ½ÃÀå, Áö¿ªº° ½ÃÀå, ±¹°¡º° ½ÃÀå µî¿¡ ´ëÇÑ Ã¼°èÀûÀÎ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù.

¸ñÂ÷

COVID-19 ÆÒµ¥¹Í °ü·Ã Á¦Ç° ½ÃÀå : Á¦1±Ç

Á¦1Àå ½ÃÀå Á¤ÀÇ

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå COVID-19(SARS-CoV-2) ÆÒµ¥¹Í

Á¦4Àå ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ

Á¦5Àå ½ÃÀå ¼ºÀå ÀúÇØ¿äÀÎ

Á¦6Àå ½ÃÀå SWOT ºÐ¼®

Á¦7Àå ºñÁö´Ï½º ±âȸ¿Í °úÁ¦

Á¦8Àå COVID-19 ÆÒµ¥¹Í °ü·Ã ¾÷°è

Á¦9Àå COVID-19 ÆÒµ¥¹Í °ü·Ã Á¦Ç° ¾÷°è : Five Forces ºÐ¼®

¼¼°è ½ÃÀå

Á¦10Àå ¼¼°èÀÇ COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

COVID-19 ÆÒµ¥¹Í °ü·Ã Á¦Ç° ½ÃÀå : Á¦2±Ç

Á¦Ç°/¼­ºñ½º ½ÃÀå

Á¦1Àå COVID-19 ¹é½Å ½ÃÀå

Á¦2Àå COVID-19 °¨¿° ÈÄ Ä¡·áÁ¦ ½ÃÀå

Á¦3Àå ±âŸ Á¦¾à ¾÷°è Á¦Ç° - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦4Àå PCR °Ë»ç Àåºñ¡¤¼ÒÇÁÆ®¿þ¾î - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦5Àå ·Îº¿ PCR °Ë»ç ½Ã½ºÅÛ¡¤¼ÒÇÁÆ®¿þ¾î - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦6Àå PCR ½Ã¾à¡¤¼Ò¸ðǰ - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦7Àå ÄÚ¡¤ÀÔ¿ë ½º¿Ò - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦8Àå ÀÚ±â ȸ¼ö PCR °Ë»ç ŰƮ - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦9Àå Ç÷û °Ë»ç ŰƮ - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦10Àå ½ºÅĵå¿ÀÇÁÇü ü¿Â°è - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦11Àå X¼± °Ë»ç - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦12Àå CT °Ë»ç - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦13Àå ÃÊÀ½ÆÄ °Ë»ç - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦14Àå FDG-PET/CT °Ë»ç¡¤Æó¼ö °Ë»ç - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦15Àå PACS¡¤¿ø°Ý¹æ»ç¼± - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦16Àå PPE °¡¿î - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦17Àå Àå°© - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦18Àå ÆäÀ̽º ¸¶½ºÅ© - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦19Àå ÀÇ·á¿ë ÆäÀ̽º ½Çµå - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦20Àå ´« º¸È£ - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦21Àå PPE ¸ê±Õ : ½Ã½ºÅÛ¡¤¼Ò¸ðǰ - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦22Àå ¼Õ¡¤Ç¥¸é ¼Òµ¶Á¦ - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦23Àå Á¦¿° - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦24Àå ±âŸ °³ÀÎ¿ë ¹æÈ£±¸ - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦25Àå AI¡¤ºòµ¥ÀÌÅÍ¡¤µö·¯´× - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦26Àå ÀçÅà ÀÇ·á IT - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦27Àå Áö¸® °¨½Ã ½Ã½ºÅÛ¡¤¼­ºñ½º - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦28Àå E-Health - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦29Àå ºí·ÏüÀÎ ±â¼ú - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦30Àå ±âŸ ICT - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦31Àå ºñħ½ÀÀû ÀΰøÈ£Èí±â - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦32Àå ħ½ÀÀû ÀΰøÈ£Èí±â - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦33Àå Â÷¼¼´ë ÀΰøÈ£Èí±â - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦34Àå ÀçÅà "ICU"(Àåºñ¡¤¼ÒÇÁÆ®¿þ¾î¡¤¼­ºñ½º) - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦35Àå ±ä±Þ ´ëÀÀ º´¿ø - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦36Àå ½ÅÀå Åõ¼® - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦37Àå ECMO ´ëÀÀ - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦38Àå ±âŸ ÁýÁß Ä¡·á ¸ð´Þ¸®Æ¼ - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦39Àå °¡¿î Á¦Á¶ °øÀå - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦40Àå Àå°© Á¦Á¶ °øÀå - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦41Àå ÆäÀ̽º ¸¶½ºÅ© Á¦Á¶ °øÀå - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦42Àå ÆäÀ̽º ½Çµå Á¦Á¶ °øÀå - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦43Àå Ç÷û °Ë»ç ŰƮ Á¦Á¶ °øÀå - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦44Àå ¸áÆ®ºí·Î¿î PPE ÆÐºê¸¯ Á¦Á¶ °øÀå - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦45Àå ½ºÆÝº»µå PPE ÆÐºê¸¯ Á¦Á¶ °øÀå - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦46Àå ÀÚ±â ȸ¼ö PCR °Ë»ç ŰƮ Á¦Á¶ °øÀå - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦47Àå ÀΰøÈ£Èí±â Á¦Á¶ °øÀå - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦48Àå PCR ½Ã¾à Á¦Á¶ °øÀå - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦49Àå PCR °Ë»ç ½Ã½ºÅÛ Á¦Á¶ °øÀå - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦50Àå ÄÚ¡¤ÀÔ¿ë ½º¿Ò Á¦Á¶ °øÀå - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦51Àå ÀÇ·á¿ë À¯¸®¡¤±âŸ Á¦Á¶ °øÀå - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦52Àå R&D Àåºñ¡¤¼Ò¸ðǰ - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦53Àå ÀÇ·á¿ë À¯¸®¡¤±âŸ Á¦Ç°¡¤¼­ºñ½º - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

COVID-19 ÆÒµ¥¹Í °ü·Ã Á¦Ç° ½ÃÀå : Á¦3±Ç

¾÷Á¾º° ½ÃÀå

Á¦1Àå º´¿ø¡¤¿Ü°ú º´¿ø - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦2Àå ÀÓ»ó °Ë»ç½Ç - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦3Àå Ŭ¸®´Ð - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦4Àå ÀÀ±ÞÀÇ·á¼­ºñ½º(EMS) - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦5Àå ÀçÅà Äɾ¿ä¾ç¿ø - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦6Àå ¿¬±¸±â°ü - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Áö¿ªº° ½ÃÀå

Á¦7Àå ºÏ¹Ì - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦8Àå À¯·´ - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦9Àå ¾Æ½Ã¾ÆÅÂÆò¾ç - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦10Àå Áßµ¿¡¤¾ÆÇÁ¸®Ä«¡¤¶óƾ¾Æ¸Þ¸®Ä« - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

±¹°¡º° ½ÃÀå

Á¦11Àå ¹Ì±¹ - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦12Àå ij³ª´Ù - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦13Àå ¿µ±¹ - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦14Àå µ¶ÀÏ - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦15Àå ÇÁ¶û½º - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦16Àå ÀÌÅ»¸®¾Æ - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦17Àå ±âŸ À¯·´ - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦18Àå Àεµ - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦19Àå Áß±¹ - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦20Àå Çѱ¹ - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦21Àå ÀϺ» - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦22Àå ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

Á¦23Àå ¼¼°èÀÇ ±âŸ Áö¿ª - COVID-19 ÆÒµ¥¹Í °ü·Ã ½ÃÀå

COVID-19 ÆÒµ¥¹Í °ü·Ã Á¦Ç° ½ÃÀå : Á¦4±Ç

ºÎ·Ï

Á¦1Àå ºÎ·Ï 1 : ÀϹÝÀûÀÎ ÀÎÇ÷翣ÀÚ¿Í Äڷγª¹ÙÀÌ·¯½ºÀÇ Â÷ÀÌ¿Í À¯»çÁ¡

Á¦2Àå ºÎ·Ï 2 : ÀÇ·á Á¾»çÀÚ¿ë Äڷγª¹ÙÀÌ·¯½º¿ë PPE

Á¦3Àå ºÎ·Ï 3 : ´« º¸È£ - CDC °ø±Þ ÃÖÀûÈ­ Àü·«

Á¦4Àå ºÎ·Ï 4 : Àý¿¬ °¡¿î - CDC °ø±Þ ÃÖÀûÈ­ Àü·«

Á¦5Àå ºÎ·Ï 5 : ÆäÀ̽º ¸¶½ºÅ© - CDC °ø±Þ ÃÖÀûÈ­ Àü·«

Á¦6Àå ºÎ·Ï 6 : N95 ÀΰøÈ£Èí±â - CDC °ø±Þ ÃÖÀûÈ­ Àü·«

Á¦7Àå ºÎ·Ï 7 : CDC ¼ºÀÎ¿ë ¹é½Å °¡°ÝÇ¥

Á¦8Àå ºÎ·Ï 8 : CDC COVID-19 ¹ÙÀÌ¿À ¼¼ÀÌÇÁƼ °¡À̵å¶óÀÎ

Á¦9Àå ºÎ·Ï 9 : 2020 Global Desperation to Protect Medical Workers

Á¦10Àå ºÎ·Ï 10 : COVID-19¿¡ ´ëÀÀÇÑ ¼Òµ¶ ÀýÂ÷

Á¦11Àå ºÎ·Ï 11 : COVID-19 USA Medical Services Stimulus April 2020

Á¦12Àå ºÎ·Ï 12 : ½ÅÈï À¯Çິ¿¡ ´ëÇÑ À¯·´ÀÇ ´ëÀÀ

Á¦13Àå ºÎ·Ï 13 : COVID-19 Áø´Ü °Ë»ç - CDC¡¤FDA¿¡ ÀÇÇÑ °³¹ß°ú ±ÔÁ¦

Á¦14Àå ºÎ·Ï 14 : The U.S. Defense Production Act: Example FEMA COVID-19 Supply Chain Stabilization

Á¦15Àå ºÎ·Ï 15 : The Global Research Collaboration for Infectious Disease Preparedness(GLOPID-R)

Á¦16Àå ºÎ·Ï 16 : COVID-19 ÀÓ»ó µ¥ÀÌÅÍ ºñ±³(±¹°¡º°)

Á¦17Àå ºÎ·Ï 17 : ÀçÅà ÀÇ·á¿ë IT

Á¦18Àå ºÎ·Ï 18 : PCR °Ë»ç¿Í Ç×ü °Ë»çÀÇ Â÷ÀÌ

Á¦19Àå ºÎ·Ï 19 : COVID-19 ÆÒµ¥¹Í - ¼¼°è °æÁ¦¿¡ ´ëÇÑ ¿µÇâ

Á¦20Àå ºÎ·Ï 20 : COVID-19 °Ë»ç

Á¦21Àå ºÎ·Ï 21 : WHO À¯·´ Áö¿ª¿¡¼­ GeneXpert Ç÷§ÆûÀÇ ¿ªÇÒ

Á¦22Àå ºÎ·Ï 22 : ¾à¾î

Á¦23Àå ºÎ·Ï 23 : ¿ë¾îÁý

Á¦24Àå ºÎ·Ï 24 : Âü°í¹®Çå

Á¦25Àå Á¶»ç ¹æ¹ý

Á¦26Àå ¸éÃ¥»çÇ×°ú ÀúÀÛ±Ç

KSM 20.09.07
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Title:
COVID-19 Mitigation Products
(PPE, Serologic Test, Contact Tracing, COVID-19 Drugs, COVID-19 Vaccine, Polymerase Chain Reaction, PCR Test Kits, Blockchain Technologies, Surge Hospitals, Self-collection Swabs, AI, Personal Protection Gear, Teleradiology, Eye Protection, Ultrasound, Dialysis, CT, X-Ray, Blockchain Technologies, Medical Glass, Telemedicine, Face Shields, Gowns, Homecare, Gloves, E-Health, Robotic PCR, Antigen Test, Monoclonal Antibody, Face Masks, Therapeutic Drugs, ICU, PACS, PPE Sterilization and More) Market Research, to 2024.

On the backdrop of the global pandemic, a need for essential pandemic mitigation products and services emerged a new market, the COVID-19 Pandemic Mitigation Products Market.

"the COVID-19 Mitigation Products Market is a Seller's Market.....This does not happen Very Often"

To adhere to our high standards of research, as nobody can forecast the future of the pandemic, we include in the report two scenarios:

According to the report scenarios, the cumulative 2020-2024 market* size is expected to be $1.6 Trillion (scenario A, the optimistic one) and $2.2 Trillion (scenario B, conservative).

Market revenue is forecasted to reach at 2020-2024: $1.6 Trillion (scenario A); $2.2 Trillion (senario B)

(*) Market size is year and scenario dependent.

Why trust this report?

Bottom Line: While other COVID-19 market reports are written (at best) by MBAs, this report is published by seasoned professionals for industry executives.

"It's your worst nightmare, the perfect storm. .....when I say unprecedented, I mean dating back to the 1818 historic pandemic..... I think 50 years from now, people are going to be reflecting historically on this, the we used to reflect on the 1918 outbreak." Anthony Fauci, National Institute of Allergy and Infectious Diseases director, July 2020.

As we write this report, billions, the largest part of the globe's populace, are restricted to their homes or subject to social distancing, in an effort to contain one of the most terrible plagues of modern times. Trade and industry activity has dropped, millions are out of work, and whole industries have ground to a halt.

Quite understandably, a couple of issues are on your mind:

The intention of this report is to give you the answers to these questions!

The COVID-19 pandemic exposed acute deficiencies of many essential products and services, from PPE & ventilators to surge ICUs and homecare equipment, from PCR reagents to digital contact tracing systems. Never before has world leading healthcare communities been faced with the likelihood of having to ration or function without critical medical supplies and services on this magnitude.

In the beginning, it took 62 days for COVID-19 to infect 10,000 people.... On July 23rd it took only 55 minutes to infect 10,000. A growth rate of 1,653% ! No wonder trillions will be invested to save people and the economy.

COVID-19 Pandemic Mitigation Products & Services Market Segmentation Vectors

5 Regions, 13 National Markets, 6 Vertical Markets,
and 4 Revenue Source Markets:

54 Products and Services Markets:

The COVID-19 Mitigation Products Market Research presents a thorough market analysis of 54 products & services, 6 end user, 4 revenue source, 5 regional and 13 national markets. Furthermore, the report provides updated extensive data of 37 key vendors.

This 1035-page 5-volume market report is the first and most comprehensive review of the global COVID-19 Pandemic Mitigation Products & Services market available today. The objective of this report is to provide today's strategic decision-makers with an expert 360-degree, time-sensitive, detailed view of this interconnected market. The report includes the industry value chain, SWOT analysis, market drives & inhibitors, business opportunities, barriers to entry, supplier power, buyer power and barriers to substitution.

The 2024 COVID-19 Pandemic Mitigation
Products Market (Scenario A), by Region

Why Buy this Homeland Security Market Report?

A. Questions answered in this report include:

B. The COVID-19 Pandemic Mitigation Products Market size data is analyzed via 5 independent key perspectives.

With a highly fragmented market we address the "money trail" - each dollar spent in the global COVID-19 Pandemic Mitigation market is analyzed and crosschecked via 5 orthogonal viewpoints:

By 54 Products and Services:

  • 1. Vaccines
  • 2. Therapeutic Drugs
  • 3. Other COVID-19 Pharma Industry Products
  • 4. PCR Instrumentation & Software
  • 5. Robotic PCR Systems & Software
  • 6. PCR Reagents & Consumables
  • 7. Nose & Mouth Swabs
  • 8. Self-collection PCR Test Kits
  • 9. Serologic Test Kits
  • 10. Standoff Thermometry
  • 11. X-Ray Procedures
  • 12. CT Procedures
  • 13. Ultrasound Procedures
  • 14. FDG-PET/CT Procedures & Wastewater Testing
  • 15. PACS & Teleradiology
  • 16. Medical PPE Gowns
  • 17. Medical Gloves
  • 18. Medical Face Masks
  • 19. Medical Face Shields
  • 20. Medical Eye Protection
  • 21. PPE Sterilization: Systems & Consumables
  • 22. Hand & Surface Sanitizers
  • 23. Decontamination
  • 24. Other Personal Protection Gear
  • 25. AI, Big Data & Deep Learning
  • 26. Homecare IT
  • 27. Geo-Surveillance Systems & Services
  • 28. E-Health
  • 29. Blockchain Technologies
  • 30. Other ICT
  • 31. Noninvasive Ventilators
  • 32. Invasive Mechanical Ventilators
  • 33. Next Generation Ventilators
  • 34. COVID-19 Homecare (HW, SW, Services)
  • 35. Portable Ventilators
  • 36. Surge Capacity Hospitals & ICUs
  • 37. Kidney Dialysis
  • 38. Extracorporeal Membrane Oxygenation Procedures
  • 39. Other Intensive Care Modalities
  • 40. PPE Gowns Manufacturing Plants
  • 41. Gloves Manufacturing Plants
  • 42. Face Masks Manufacturing Plants
  • 43. Face Shields Manufacturing Plants
  • 44. Sorologic Test Kits Manufacturing Plants
  • 45. Melt-Blown PPE Fabric Manufacturing Plants
  • 46. Spun-Bond PPE Fabric Manufacturing Plants
  • 47. Self-collection PCR Test Kits Manufacturing Plants
  • 48. Ventilators Manufacturing Plants
  • 49. PCR Reagents Manufacturing Plants
  • 50. PCR Systems Manufacturing Plants
  • 51. Nose & Mouth Swabs Manufacturing Plants
  • 52. Medical Glass & Other Manufacturing Plants
  • 53. R&D Equipment & Consumables
  • 54. Medical Glass and Other Products & Services

By 6 End User Markets:

By 13 National Markets:

  • 1. U.S.A
  • 2. Canada
  • 3. UK
  • 4. Germany
  • 5. France
  • 6. Italy
  • 7. Rest of Europe
  • 8. India
  • 9. China
  • 10. South Korea
  • 11. Japan
  • 12. Rest of Asia Pacific
  • 13. RoW

By 5 Regional Markets:

By 4 Revenue Source Markets:

C. Detailed market analysis frameworks for each of the market sectors are provided, including:

Competitive analysis for each of the 54 products and services that covers:

D. The report provides an updated extensive data of the leading 37 companies (including companies' profile, recent annual revenues, COVID-19 mitigation activities & products and contact information).

E. The report includes over 2300 links to the COVID-19 Pandemic Mitigation community information sources

F. The report mentions > 450 Vendors including the following:

3M Company, 3Scan, Abbott , AbCellera, Advenio Technosys, Agfa Healthcare, Agilent Technologies, AiCure, Aindra, Allscripts Healthcare Solutions, Amara Health Analytics , Amazon , analyticsMD, Apixio, Apple, Arterys Inc, Atlas Wearables, Atomwise, Avalon Nutrition VITL, Babylon Health, Bay Labs, Behold.ai, benevolent.ai, BIOBEATS, BlueDot, Bollé Safety, Bullard, Buoy Health, Care Angel Wearables QorQL, Careskore, Clinithink, Cloud Pharmaceuticals, CloudMedx, CureMetrix Mental health Ginger.io, Cyrcadia, Deep 6 AI, Deep Genomics, Dell Technologies Inc., Delta Plus Group, Desktop Genetics Virtual mate Ada Health, DreaMed Diabetes, Dupont, EaglEyeMed, Eli Lilly, Encon Safety Products, Enlitic, EnsoData, Entopsis, Envisagenics Research iCarbonX, ERB Industries Inc., Ergodyne, Essilor of America, Flashback Technologies, Flow Health, Ford, Freenome, Frequency Therapeutics Inc., Fujifilm Holdings Corporation, Gateway Safety Inc., GE Healthcare, General Electric, General Motors, General Vision, Gentex Corporation, Gibco, Gilead Sciences, Globavir Biosciences, Google, Healint, Health Fidelity, HealthNextGen, HexArmor, Hindsait, Honeywell Safety Products, IBM, Imagen Technologies, Imagia Cybernetics, Infermedica, Infervision, Inovio Pharmaceuticals, Inside DNA, InSilico Medicine, Intel Corporation, Intendu, Invitrogen, Ion Torrent, Ironwear, Johnson & Johnson (Janssen), Jvion, Kapa Biosystems, Keen Eye Technologies, Kimberly-Clark Professional, Koninklijke Philips NV, Lexmark International Inc., LifeGraph, Lucina Health, Lumiata, Lunit, Lytics, Magnea, Maxim Biotech, Maxwell MRI, McKesson Corporation, MCR Safety, Medal, Medalogix, Medasense, MedAware, Medtronic, MedWhat, MedyMatch , Merck, Metabiota, Micron Technology, Microsoft Corporation, Mindshare Medical, Moderna, Morpheo, Niramai Health Analytix, Novarad Corporation, NuMedii, Numerate, Nuritas Pharma Turbine, Nvidia Corporation, Oncora Medical, Ovuline, PeerWell, Pfizer, Philips, Philips Healthcare, PhysIQ., Precision Health Intelligence, Predible Health, Profility, Proscia, pulseData, Pyramex Safety, Qualaris Healthcare Solutions, Qualcomm Incorporated, Qualcomm Incorporated, Qure. Ai, Radians Inc., Recursion Pharmaceuticals, Regeneron Pharmaceuticals, Roam Analytics , Roche, RxPREDICT, Safety Optical Service, Samsung Electronics Co., Ltd, Sanofi, Saykara, Sellstrom Manufacturing Company (SureWerx), Sense.ly, Sensory Inc., Siemens, Sigma-Aldrich Corp., Skymind Inc., Thermo Fisher Scientific, Toshiba, Vir Biotechnology Inc., VisionAid Inc., WuXi Biologics, Xilinx Inc..

G. COVID-19 Pandemic Mitigation Products & Services Market report includes 24 appendices:

COVID-19 pandemic mitigation market research team

The team which composed this report brings 43 years of hands on record in the development and commercialization of healthcare products including: antibody antigen identification, E-health, decontamination and biosecurity, PACS, teleradiology, PPE, computerized tomography, ultrasound, electron microscopy, medical devices and more. Our team members bring long term relations with the U.S. FDA and CDC as well as the EU CE and other national medical regulatory agencies.

As early as January 20, 2020 we recruited all our analysts to research the COVID-19 pandemic mitigation related products and services industries. We interviewed hundreds of experts, participated in more than 95 conferences and webinars, reviewed more than 1,500 publications and interviewed executives of more than 65 pandemic related companies. The team published six months later a set of 32 Coronavirus mitigation market reports.

Table of Contents

COVID-19 Pandemic Mitigation Products Market - 2020-2024: Volume 1

1. Market Definition

2. Executive Summary

3. The SARS CoV 2 2019 Pandemic

4. Market Drivers

5. Market Inhibitors

7. Business Opportunities & Challenges

8. COVID-19 Pandemic Mitigation Industry

9. COVID-19 Pandemic Mitigation Products Industry: Barriers to Entry, Supplier Power, Buyer Power & Barriers to Substitution

GLOBAL MARKET

10. Global COVID-19 Pandemic Mitigation Market - 2020-2024

COVID-19 Pandemic Mitigation Products Market - 2020-2024: Volume 2

PRODUCT/SERVICE MARKETS

1. COVID-19 Vaccines Market - 2020-2024

2. COVID-19 Post-Infection Therapeutic Drugs Market - 2020-2024

3. Other Pharma Industry Products COVID-19 Pandemic Mitigation Market - 2020-2024

4. PCR Instrumentation & Software COVID-19 Pandemic Mitigation Market - 2020-2024

5. Robotic PCR Systems & Software COVID-19 Pandemic Mitigation Market - 2020-2024

6. PCR Reagents & Consumables COVID-19 Pandemic Mitigation Market - 2020-2024

7. Nose & Mouth Swabs COVID-19 Pandemic Mitigation Market - 2020-2024

8. Self-collection PCR Test Kits COVID-19 Pandemic Mitigation Market - 2020-2024

9. Serologic Test Kits COVID-19 Pandemic Mitigation Market - 2020-2024

10. Standoff Thermometry COVID-19 Pandemic Mitigation Market - 2020-2024

11. X-Ray Procedures COVID-19 Pandemic Mitigation Market - 2020-2024

12. CT Procedures COVID-19 Pandemic Mitigation Market - 2020-2024

13. Ultrasound Procedures COVID-19 Pandemic Mitigation Market - 2020-2024

14. FDG-PET/CT Procedures & Wastewater Testing COVID-19 Pandemic Mitigation Market - 2020-2024

15. PACS & Teleradiology COVID-19 Pandemic Mitigation Market - 2020-2024

16. PPE Gowns COVID-19 Pandemic Mitigation Market - 2020-2024

17. Gloves COVID-19 Pandemic Mitigation Market - 2020-2024

18. Face Masks COVID-19 Pandemic Mitigation Market - 2020-2024

19. Medical Face Shields COVID-19 Pandemic Mitigation Market - 2020-2024

20. Eye Protection COVID-19 Pandemic Mitigation Market - 2020-2024

21. PPE Sterilization: Systems & Consumables COVID-19 Pandemic Mitigation Market - 2020-2024

22. Hand & Surface Sanitizers COVID-19 Pandemic Mitigation Market - 2020-2024

23. Decontamination COVID-19 Pandemic Mitigation Market - 2020-2024

24. Other Personal Protection Gear COVID-19 Pandemic Mitigation Market - 2020-2024

25. AI, Big Data & Deep Learning COVID-19 Pandemic Mitigation Market - 2020-2024

26. Homecare IT COVID-19 Pandemic Mitigation Market - 2020-2024

27. Geo-Surveillance Systems & Services COVID-19 Pandemic Mitigation Market - 2020-2024

28. E-Health COVID-19 Pandemic Mitigation Market - 2020-2024

29. Blockchain Technologies COVID-19 Pandemic Mitigation Market - 2020-2024

30. Other ICT COVID-19 Pandemic Mitigation Market - 2020-2024

31. Noninvasive Ventilators COVID-19 Pandemic Mitigation Market - 2020-2024

32. Invasive Mechanical Ventilators COVID-19 Pandemic Mitigation Market - 2020-2024

33. Next Generation Ventilators COVID-19 Pandemic Mitigation Market - 2020-2024

34. Homecare "ICU" (Equipment, Software, Services) COVID-19 Pandemic Mitigation Market - 2020-2024

35. Surge Capacity Hospitals COVID-19 Pandemic Mitigation Market - 2020-2024

36. Kidney Dialysis COVID-19 Pandemic Mitigation Market - 2020-2024

37. Extracorporeal Membrane Oxygenation Procedures COVID-19 Pandemic Mitigation Market - 2020-2024

38. Other Intensive Care Modalities COVID-19 Pandemic Mitigation Market - 2020-2024

39. Gowns Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024

40. Gloves Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024

41. Face Masks Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024

42. Face Shields Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024

43. Serologic Test Kits Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024

44. Melt-Blown PPE Fabric Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024

45. Spun-Bond PPE Fabric Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024

46. Self-collection PCR Test Kits Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024

47. Ventilators Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024

48. PCR Reagents Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024

49. PCR Systems Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024

50. Nose & Mouth Swabs Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024

51. Medical Glass & Other Manufacturing Plants COVID-19 Pandemic Mitigation Market - 2020-2024

52. R&D Equipment & Consumables COVID-19 Pandemic Mitigation Market - 2020-2024

53. Medical Glass and Other Products & Services COVID-19 Pandemic Mitigation Market - 2020-2024

COVID-19 Pandemic Mitigation Products Market - 2020-2024: Volume 3

VERTICAL MARKETS

1. Hospitals and Surge Hospitals COVID-19 Pandemic Mitigation Market - 2020-2024

2. Clinical Labs COVID-19 Pandemic Mitigation Market - 2020-2024

3. Clinics COVID-19 Pandemic Mitigation Market - 2020-2024

4. Emergency Medical Services (EMS) COVID-19 Pandemic Mitigation Market - 2020-2024

5. Homecare & Nursing Homes COVID-19 Pandemic Mitigation Market - 2020-2024

6. Research Bodies COVID-19 Pandemic Mitigation Market - 2020-2024

REGIONAL MARKETS

7. North America COVID-19 Pandemic Mitigation Market - 2020-2024

8. Europe COVID-19 Pandemic Mitigation Market - 2020-2024

9. Asia-Pacific COVID-19 Pandemic Mitigation Market - 2020-2024

10. MEA & Latin America COVID-19 Pandemic Mitigation Market - 2020-2024

NATIONAL MARKETS

11. USA COVID-19 Pandemic Mitigation Market - 2020-2024

12. Canada COVID-19 Pandemic Mitigation Market - 2020-2024

13. U.K. COVID-19 Pandemic Mitigation Market - 2020-2024

14. Germany COVID-19 Pandemic Mitigation Market - 2020-2024

15. France COVID-19 Pandemic Mitigation Market - 2020-2024

16. Italy COVID-19 Pandemic Mitigation Market - 2020-2024

17. Rest of Europe COVID-19 Pandemic Mitigation Market - 2020-2024

18. India COVID-19 Pandemic Mitigation Market - 2020-2024

19. China COVID-19 Pandemic Mitigation Market - 2020-2024

20. South Korea COVID-19 Pandemic Mitigation Market - 2020-2024

21. Japan COVID-19 Pandemic Mitigation Market - 2020-2024

22. Rest of Asia-Pacific COVID-19 Pandemic Mitigation Market - 2020-2024

23. ROW COVID-19 Pandemic Mitigation Market - 2020-2024

COVID-19 Pandemic Mitigation Products Market - 2020-2024: Volume 4

APPENDICES

1. Appendix 1: Differences & Similarities Between Common Flu and Coronavirus

2. Appendix 2: Coronavirus Personal Protective Equipment (PPE) for Healthcare Personnel

3. Appendix 3: CDC Strategies for Optimizing the Supply of Eye Protection

4. Appendix 4: CDC Strategies for Optimizing the Supply of Isolation Gowns

5. Appendix 5: CDC Strategy for Optimizing the Supply of Facemasks

6. Appendix 6: CDC Strategies for Optimizing the Supply of N95 Respirators

7. Appendix 7: CDC Adult Vaccine Price List

8. Appendix 8: The CDC COVID-19 Bio-Safety Guidelines

9. Appendix 9: The 2020 Global Desperation to Protect Medical Workers

10. Appendix 10: Disinfection Procedures for COVID-19

11. Appendix 11: Breakdown of the COVID-19 USA Medical Services Stimulus April 2020

12. Appendix 12: European Preparedness Against Emerging Epidemics

13. Appendix 13: Development and Regulation by the CDC and FDA Diagnostic Testing for COVID-19

14. Appendix 14: The U.S. Defense Production Act: Example FEMA COVID-19 Supply Chain Stabilization

15. Appendix 15: The Global Research Collaboration for Infectious Disease Preparedness (GLOPID-R)

16. Appendix 16: Comparing Clinical COVID-19 Data by Nation

17. Appendix 17: Home Healthcare IT

18. Appendix 18: The Difference between PCR and Antibody Tests

19. Appendix 19: COVID-19 Pandemic Global Economic Effects- 2020-2021

20. Appendix 20: COVID-19 Tests

21. Appendix 21: Rapid Communication on the Role of the GeneXpert® Platform for Rapid Molecular Testing for SARS-CoV-2 in the WHO European Region

22. Appendix 22: Abbreviations

23. Appendix 23: Glossary

24. Appendix 24: Bibliography

25. Research Methodology

26. Disclaimer & Copyright

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â